Medtronic
MDT
$1.45 (1.71%)
1D
1W
3M
1Y
5Y
ALL
Medtronic Public Limited Company is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients. The Company has four operating and reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiovascular Portfolio, the Medical Surgical Portfolio, the Neuroscience Portfolio, and the Diabetes Operating Unit. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 5 hours ago • MDT
MDT Stock Gains From FDA Approval for Its InPen AppZacks Investment Research • 1 day ago • MDT
Here's Why Medtronic (MDT) is a Strong Value StockMarketBeat • 1 day ago • MDT
Medtronic: A Dividend Aristocrat Powering Up for 2025 and BeyondThe Motley Fool • 1 day ago • MDT
3 Dividend Stocks I'll Never SellPRNewsWire • 2 days ago • MDT
Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGMCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.